doi:10.1073/pnas.97.10.5440 31
Patients with primarily subcutaneous fat accumulation on the abdomen, hips, and thighs may see modest improvement in body composition but should not expect the same degree of change that someone with significant visceral fat load will experience
Researchers measured endpoints like fasting glucose, HbA1c, insulin resistance, and lipid profiles across the different doses
Whether you are a good candidate for a GLP-1 (Glucagon-like peptide 1) weight-loss program depends on your health profile, medical history, lifestyle, body mass index (BMI), and other factors
Thyroid C-cell tumors (rodent signal) - GLP-1 RAs carry a boxed warning regarding an increased risk of thyroid C-cell tumors in rodents
Reconstitution ratios by vial size The general guideline follows a simple ratio